Vanguard Group’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-18,981
| Closed | -$8.54K | – | 4484 |
|
|
2024
Q1 | $8.54K | Hold |
18,981
| – | – | ﹤0.01% | 4432 |
|
|
2023
Q4 | $14K | Hold |
18,981
| – | – | ﹤0.01% | 4465 |
|
|
2023
Q3 | $16.5K | Hold |
18,981
| – | – | ﹤0.01% | 4508 |
|
|
2023
Q2 | $35.5K | Buy |
18,981
+143
| +0.8% | +$471 | ﹤0.01% | 4491 |
|
|
2023
Q1 | $69.7K | Sell |
18,838
-28,446
| -60% | -$131K | ﹤0.01% | 4435 |
|
|
2022
Q4 | $180K | Sell |
47,284
-5,669
| -11% | -$29.1K | ﹤0.01% | 4327 |
|
|
2022
Q3 | $419K | Hold |
52,953
| – | – | ﹤0.01% | 4262 |
|
|
2022
Q2 | $1.11M | Hold |
52,953
| – | – | ﹤0.01% | 4052 |
|
|
2022
Q1 | $1.99M | Sell |
52,953
-15,279
| -22% | -$528K | ﹤0.01% | 3960 |
|
|
2021
Q4 | $3.83M | Sell |
68,232
-85
| -0.1% | -$5.71K | ﹤0.01% | 3758 |
|
|
2021
Q3 | $4.93M | Buy |
68,317
+3,425
| +5% | +$262K | ﹤0.01% | 3671 |
|
|
2021
Q2 | $6.22M | Buy |
64,892
+16,950
| +35% | +$1.87M | ﹤0.01% | 3476 |
|
|
2021
Q1 | $7.09M | Buy |
47,942
+1,697
| +4% | +$308K | ﹤0.01% | 3350 |
|
|
2020
Q4 | $6.46M | Buy |
46,245
+417
| +0.9% | +$67.6K | ﹤0.01% | 3221 |
|
|
2020
Q3 | $6.96M | Buy |
45,828
+39,399
| +613% | +$6.43M | ﹤0.01% | 2982 |
|
|
2020
Q2 | $1.13M | Buy |
6,429
+4,374
| +213% | +$732K | ﹤0.01% | 3581 |
|
|
2020
Q1 | $293K | Hold |
2,055
| – | – | ﹤0.01% | 3796 |
|
|
2019
Q4 | $296K | Hold |
2,055
| – | – | ﹤0.01% | 3881 |
|
|
2019
Q3 | $205K | Buy |
2,055
+725
| +55% | +$71.6K | ﹤0.01% | 3958 |
|
|
2019
Q2 | $91K | Hold |
1,330
| – | – | ﹤0.01% | 4059 |
|
|
2019
Q1 | $60K | Hold |
1,330
| – | – | ﹤0.01% | 4051 |
|
|
2018
Q4 | $46K | Sell |
1,330
-3,402
| -72% | -$246K | ﹤0.01% | 4078 |
|
|
2018
Q3 | $350K | Hold |
4,732
| – | – | ﹤0.01% | 3909 |
|
|
2018
Q2 | $371K | Sell |
4,732
-89
| -2% | -$7.77K | ﹤0.01% | 3876 |
|
|
2018
Q1 | $424K | Buy |
4,821
+742
| +18% | +$110K | ﹤0.01% | 3817 |
|
|
2017
Q4 | $3.04M | Buy |
4,079
+1,258
| +45% | +$486K | ﹤0.01% | 3301 |
|
|
2017
Q3 | $812K | Buy |
2,821
+790
| +39% | +$216K | ﹤0.01% | 3642 |
|
|
2017
Q2 | $520K | Buy |
2,031
+14
| +0.7% | +$3.76K | ﹤0.01% | 3720 |
|
|
2017
Q1 | $670K | Buy |
2,017
+59
| +3% | +$27.3K | ﹤0.01% | 3687 |
|
|
2016
Q4 | $1.18M | Sell |
1,958
-349
| -15% | -$369K | ﹤0.01% | 3511 |
|
|
2016
Q3 | $2.61M | Hold |
2,307
| – | – | ﹤0.01% | 3294 |
|
|
2016
Q2 | $2.53M | Buy |
2,307
+25
| +1% | +$31.4K | ﹤0.01% | 3286 |
|
|
2016
Q1 | $2.93M | Buy |
2,282
+279
| +14% | +$398K | ﹤0.01% | 3220 |
|
|
2015
Q4 | $4.92M | Buy |
2,003
+191
| +11% | +$293K | ﹤0.01% | 2991 |
|
|
2015
Q3 | $2M | Buy |
1,812
+273
| +18% | +$316K | ﹤0.01% | 3376 |
|
|
2015
Q2 | $1.54M | Buy |
1,539
+17
| +1% | +$18.3K | ﹤0.01% | 3520 |
|
|
2015
Q1 | $1.55M | Buy |
1,522
+121
| +9% | +$399K | ﹤0.01% | 3498 |
|
|
2014
Q4 | $4.67M | Buy |
1,401
+42
| +3% | +$129K | ﹤0.01% | 2934 |
|
|
2014
Q3 | $3.94M | Buy |
1,359
+113
| +9% | +$374K | ﹤0.01% | 2959 |
|
|
2014
Q2 | $4.74M | Buy |
1,246
+401
| +47% | +$1.51M | ﹤0.01% | 2861 |
|
|
2014
Q1 | $4.6M | Buy |
845
+677
| +403% | +$3.57M | ﹤0.01% | 2867 |
|
|
2013
Q4 | $529K | Buy |
168
+138
| +460% | +$426K | ﹤0.01% | 3580 |
|
|
2013
Q3 | $97K | Buy |
+30
| New | +$81.8K | ﹤0.01% | 3774 |
|